ロード中...
Cholecalciferol Additively Reduces Serum Parathyroid Hormone and Increases Vitamin D and Cathelicidin Levels in Paricalcitol-Treated Secondary Hyperparathyroid Hemodialysis Patients
Background: Active Vitamin D analogues are used clinically for prevention and treatment of secondary hyperparathyroidism (SHPT) in hemodialysis (HD) patients. Nutritional vitamin D supplementation is used for additional local parathyroid (PTH) suppression, with lower incidence of hypercalcemia and h...
保存先:
| 出版年: | Nutrients |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5133095/ https://ncbi.nlm.nih.gov/pubmed/27827962 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/nu8110708 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|